Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

197 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

3 Russell 2000 Stocks We Approach with Caution

By: StockStory

May 04, 2026 at 00:31 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

MNRO Cover Image

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.

Picking the right small caps isn’t easy, and that’s exactly why StockStory exists - to help you focus on the best opportunities. Keeping that in mind, here are three Russell 2000 stocks to avoid and better alternatives to consider.

Monro (MNRO)

Market Cap: $527.7 million

Started as a single location in Rochester, New York, Monro (NASDAQ: MNRO) provides common auto services such as brake repairs, tire replacements, and oil changes.

Why Do We Steer Clear of MNRO?

Store closures and disappointing same-store sales suggest demand is sluggish and it’s rightsizing its operations
Poor same-store sales performance over the past two years indicates it’s having trouble bringing new shoppers into its brick-and-mortar locations
Performance over the past three years shows each sale was less profitable as its earnings per share dropped by 30.4% annually, worse than its revenue

Monro is trading at $17.56 per share, or 30.4x forward P/E. Dive into our free research report to see why there are better opportunities than MNRO.

American Outdoor Brands (AOUT)

Market Cap: $120.9 million

Spun off from Smith and Wesson in 2020, American Outdoor Brands (NASDAQ: AOUT) is an outdoor and recreational products company that offers outdoor and shooting sports products but does not sell firearms themselves.

Why Should You Sell AOUT?

Annual sales declines of 4.3% for the past five years show its products and services struggled to connect with the market
Low free cash flow margin of 1.3% for the last two years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders
Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned

At $9.57 per share, American Outdoor Brands trades at 36.2x forward P/E. Check out our free in-depth research report to learn more about why AOUT doesn’t pass our bar.

Tandem Diabetes (TNDM)

Market Cap: $1.33 billion

With technology that automatically adjusts insulin delivery based on continuous glucose monitoring data, Tandem Diabetes Care (NASDAQ: TNDM) develops and manufactures automated insulin delivery systems that help people with diabetes manage their blood glucose levels.

Why Do We Pass on TNDM?

Incremental sales over the last five years were much less profitable as its earnings per share fell by 18.5% annually while its revenue grew
Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions
Negative earnings profile makes it challenging to secure favorable financing terms from lenders

Tandem Diabetes’s stock price of $19.58 implies a valuation ratio of 25.7x forward EV-to-EBITDA. To fully understand why you should be careful with TNDM, check out our full research report (it’s free).

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	270.13	+0.00 (0.00%)
AAPL	298.87	+0.00 (0.00%)
AMD	445.50	+0.00 (0.00%)
BAC	49.84	+0.00 (0.00%)
GOOG	399.04	+0.00 (0.00%)
META	616.63	+0.00 (0.00%)
MSFT	405.21	+0.00 (0.00%)
NVDA	225.83	+0.00 (0.00%)
ORCL	189.76	+0.00 (0.00%)
TSLA	445.27	+0.00 (0.00%)